Srphc82281235-coronary Drug Eluting Stents With (1) Stent On Cobalt Chromium Alloyor Platinum Chromium Alloy. (2) Stent With Coating Of Polymer Carrier For Active Drug ( Sirolimus, Everolimus Or Zotarolimus Shown To Be Effective In Preventing Neo-intimal Hyperplasia) (3) Stent Diameter Should Be From 2.5mm To 4mm And Length Of The Stent From 12mm To 38 Mm. (4) The Strut Thickness Should Be 91 Micron Or Less. (5) Stent Delivery System Should Be Monorail (single Operator Exchange Or Rapid Exchange). (6) Stent Should Be Compatible With 5fr Guiding Catheter (7) Stent Design Should Be Open Cell Type. (8) Stent Should Be Approved By Dcgi. The Copy Of Dcgi Approval Should Be Enclosed In The Tender Bid. (9) The Long Term Efficacy And Safety Of The Stent In Terms Oftarget Vessel Revascularisation (tvr) And In-situ Thrombosis (ist) Should Be Documented / Published In Peer Reviewed Scientific Journals.(10) The Documents Pertaining To The Efficacy And Safety Of The Stent Should Be Enclosed For The Brand That Is Offered In The Tender Bid (11) The Manufacturer/supplier Should Submit Proof Of Supply Of The Stent To A Major Government Institute.[quantity Tolerance (+/-): 5 %age , Item Category : Normal , Total Po Value Variation Permitted: Max 8 Lacs ] Delivery/work location: Perambur, Tamil Nadu. This is a Open tender. Bid closing date: 03-06-2026.

Detailed eligibility criteria are available in the tender document.
Download document →